You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
|
|---|---|
| Published in |
Frontiers in Pharmacology, September 2020
|
| DOI | 10.3389/fphar.2020.586110 |
| Pubmed ID | |
| Authors |
Umberto Raucci, Nicola Pietrafusa, Maria Chiara Paolino, Giovanni Di Nardo, Maria Pia Villa, Piero Pavone, Gianluca Terrin, Nicola Specchio, Pasquale Striano, Pasquale Parisi |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 17% |
| Unknown | 5 | 83% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 67% |
| Practitioners (doctors, other healthcare professionals) | 2 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 121 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 19 | 16% |
| Researcher | 15 | 12% |
| Student > Ph. D. Student | 7 | 6% |
| Unspecified | 6 | 5% |
| Student > Postgraduate | 6 | 5% |
| Other | 23 | 19% |
| Unknown | 45 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 18% |
| Biochemistry, Genetics and Molecular Biology | 13 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 10% |
| Agricultural and Biological Sciences | 6 | 5% |
| Unspecified | 6 | 5% |
| Other | 13 | 11% |
| Unknown | 49 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2023.
All research outputs
#4,941,590
of 24,573,729 outputs
Outputs from Frontiers in Pharmacology
#2,249
of 18,600 outputs
Outputs of similar age
#114,331
of 417,619 outputs
Outputs of similar age from Frontiers in Pharmacology
#71
of 408 outputs
Altmetric has tracked 24,573,729 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,600 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 417,619 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 408 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.